There’s a lot to look forward to at DeviceTalks Boston, June 5–6 at the Seaport World Trade Center.
Sarah Faulkner, Program Manager – DeviceTalks
Eight years ago, DeviceTalks kicked off its inaugural event in Boston with a keynote interview featuring soon-to-be Covidien CEO Joe Almeida. A panel of next-generation executives included Abiomed chief Michael Minogue, Zoll’s Rick Packer and David Lucchino, then of Semprus Biossciences. And the recently installed director of the CDRH, Dr. Jeffrey Shuren, made a last-minute appearance.
It’s safe to say that things have changed since then. We’ve grown DeviceTalks into a two-day educational forum designed to bring together engineers, commercialization professionals and medtech leaders to share the challenges and best practices of getting medical devices to the market. The program now runs three times a year in Boston, Minnesota and California.
Here are some of the highlights from this year’s DeviceTalks Boston event, slated for June 5-6:
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.